Medtronic

MDT

Global leader in medical technology, services, and solutions. Pioneer in cardiac pacing, spinal surgery, insulin pumps, and surgical navigation.

FDA ClearedCE MarkFortune 500

$88.45

+2.3%

Market Data

Headquarters

Dublin, Ireland / Minneapolis, MN

CEO

Geoff Martha

Founded

1949

Employees

95,000+

Sector

Diversified MedTech

Therapeutic Area

Cardiovascular, Neuroscience, Diabetes

Stage

Public

Total Funding

Public (NYSE: MDT)

Regulatory Pipeline

MiniMed 780G Insulin Pump

510(k) · Class III · Apr 2023

Cleared

Hugo RAS System

PMA · Class III · Jan 2024

Pending

Micra AV Pacemaker

PMA · Class III · Sep 2022

Approved

StealthStation S8

510(k) · Class II · Nov 2023

Cleared

Funding History

IPO

1977

$1.2B

NYSE

Clinical Trials

HUGO RAS Pivotal Trial

Recruiting

Phase III · US, EU

Simplera CGM Study

Completed

Phase II · US

Open Positions

Senior Robotics Engineer

Surgical Robotics · Minneapolis, MN

$150K-$190K+ RSUs

RoboticsAI/MLC++

Regulatory Affairs Manager

Quality · Dublin, Ireland

$120K-$150K+ RSUs

FDACE MarkISO 13485

← Back to Directory